Re-evaluating COPD risk: Just a matter of definition

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 7, 2011, Pages 837-838

  Wood, Alice M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIR POLLUTION; ASTHMA; BODY MASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; DIAGNOSTIC TEST; DISEASE COURSE; EDITORIAL; GENETIC ANALYSIS; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SPIROMETRY;

ADULT; AGE FACTORS; ASTHMA; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; SMOKING; TERMINOLOGY AS TOPIC; YOUNG ADULT;

EID: 79953323659     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201011-1797ED     Document Type: Editorial

References (12)

1. Global Initiative for Obstructive Lung Disease Available from. www.goldcopd.com. Accessed 5th November 2010.
2. Miller MR, Hankinson J, Enright P, van der Grinten CPM, Gustafson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, et al. ATS/ERS standardisation of lung function testing: standardisation of spirometry. Eur Respir J 2005;26:319-338.
3. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80 percent of predicted and fixed thresholds misclassifies over 20% of patients. Chest 2010; (In press).
4. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabri LM, Goldin JG, Jones PW, Macnee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
5. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al.COPD in Never-Smokers: Results from the population-based BOLD Study Chest. (2010). In press
6. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernandez-Fau L. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-989.
7. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-939. (Pubitemid 44787161)
8. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693-718.
9. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA; Lung Health Study Research Group. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:1802-1811. (Pubitemid 26187903)
10. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorenson TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study Am J Respir. Crit Care Med 2006;173:79-83.
11. de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, et al.; European Community Respiratory Health Survey (ECRHS). Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011;183:891-897.
12. Pillai SG, Kong X, Edwards LD, Cho M, Anderson WH, Coxson HO, et al. Loci identified by genome-wide association studies influence different disease-related phenotypes in COPD. Am J Respir Crit Care Med (In press)